The Marshfield Clinic Personalized Medicine Research Project: 2008 Scientific Update and Lessons Learned in the First 6 Years

• Kaiser J : Population databases boom, from Iceland to the U.S.Science298 , 1158–1161 (2002).
   PubMed Web of Science ®Google Scholar
• Collins FS , GreenED, GuttmacherAE, GuyerMS: A vision for the future of genetics research. A blueprint for the genomic era.Nature422 , 835–847 (2003).
   PubMed Web of Science ®Google Scholar
• McCarty CA , WilkeRA, GiampietroPF, WesbrookSD, CaldwellMD: Marshfield Clinic Personalized Medicine Research Project (PMRP): design, methods and recruitment for a large population-based biobank.Personalized Med.2 , 49–79 (2005).
   PubMedGoogle Scholar
• Manolio TA , CollinsFS: Genes, environment, health, and disease: facing up to complexity.Hum. Hered.63 , 63–66 (2007).
   PubMed Web of Science ®Google Scholar
• Willett W : Nutritional Epidemiology. Oxford University Press, NY, USA (1990).
   Google Scholar
• Margetts BM , NelsonM (Eds): Design Concepts in Nutritional Epidemiology. Oxford University Press, Oxford, UK (1991).
   Google Scholar
• Subar AF , ThompsonFE, KipnisV et al.: Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America‘s Table Study. Am. J. Epidemiol.154 , 1089–1099 (2001).
   PubMed Web of Science ®Google Scholar
• Millen AE , MidthuneD, ThompsonFE, KipnisV, SubarAF: The National Cancer Institute diet history questionnaire: validation of pyramid food servings.Am. J. Epidemiol.163 , 279–288 (2005).
   PubMed Web of Science ®Google Scholar
• Flood A , SubarAF, HulllSG, ZimmermanTP, JenkinsDJA, SchatzkinA: Methodology for adding glycemic load values to the National Cancer Institute diet history questionnaire database.J. Am. Diet. Assoc.106 , 393–402 (2006).
   PubMedGoogle Scholar
• Subar AF , MidthuneD, KulldorffM et al.: Evaluation of alternative approaches to assign nutrient values to food groups in food frequency questionnaires. Am. J. Epidemiol.152 , 279–286 (2000).
   PubMed Web of Science ®Google Scholar
• Thompson FE , SubarAF, BrownCC et al.: Cognitive research enhances accuracy of food frequency questionnaire reports: results of an experimental validation study. J. Am. Diet. Assoc.102 , 212–225 (2002).
   PubMed Web of Science ®Google Scholar
• Subar AF , ZieglerRG, ThompsonFE et al.: Is shorter always better? Relative importance of questionnaire length and cognitive ease on response rates and data quality for two dietary questionnaires. Am. J. Epidemiol.153 , 404–409 (2001).
   PubMed Web of Science ®Google Scholar
• Subar AF , ThompsonFE, SmithAF et al.: Improving food frequency questionnaires: a qualitative approach using cognitive interviewing. J. Am. Diet. Assoc.95 , 781–788 (1995).
   PubMedGoogle Scholar
• Baecke JAH , BuremaJ, FrijtersJER: A short questionnaire for the measurement of habitual physical activity in epidemiological studies.Am. J. Clin. Nutr.36 , 936–942 (1982).
   PubMed Web of Science ®Google Scholar
• Richardson MT , AinsworthBE, Wu H-C, Jacobs DR, Leon AS: Ability of the Atherosclerosis Risk in Communities (ARIC)/Baecke questionnaire to assess leisure-time activity. Int. J. Epidemiol.24 , 685–693 (1995).
   PubMed Web of Science ®Google Scholar
• Pols MA , PeetersPHM, Bueno-de-MesquitaHB et al.: Validity and repeatability of a modified Baecke questionnaire on physical activity. Int. J. Epidemiol.24 , 381–387 (1995).
   PubMed Web of Science ®Google Scholar
• Tehard B , SarisWHM, AstrupA et al.: Comparison of two physical activity questionnaires in obese subjects: the NUGENOB study. Med. Sci. Sport Exerc.37 , 1535–1541 (2005).
   PubMed Web of Science ®Google Scholar
• McCarty CA , MukeshBN, GiampietroPF, WilkeRA: Healthy People 2010 disease prevalence in the Marshfield Clinic Personalized Medicine Research Project: opportunities for public health genomic research.Personalized Med.4 , 183–190 (2007).
   PubMed Web of Science ®Google Scholar
• Wilke RA , ReifDG, MooreJH: Combinatorial pharmacogenetics.Nat. Rev. Drug Discov.4 , 911–918 (2005).
   PubMed Web of Science ®Google Scholar
• Wilke RA , MareeduRK, MooreJH: The pathway less traveled – moving from candidate genes to candidate pathways in the analysis of genome-wide data from large scale pharmacogenetic association studies.Curr. Pharmacogenom.Pers. Med. (2008) (In Press).
   PubMedGoogle Scholar
• Helgadottir A , ThorleifssonG, Magnusson KP et al.: The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat. Genet.40 , 217–224 (2008).
   PubMed Web of Science ®Google Scholar
• McCarty CA , MukeshBN, KitchnerTE et al.: Intraocular pressure response to medication in a clinical practice-based cohort – the Marshfield Clinic Personalized Medicine Research Project (PMRP). J. Glaucoma. (2007) (In Press).
   Google Scholar
• McCarty CA , BurmesterJK, MukeshBN, PatchettR, WilkeRA: Intraocular pressure response to topical β-blockers is associated with an ADRB2 SNP.Arch. Ophthalmol.126 , 959–963 (2008).
   PubMedGoogle Scholar
• Sidjanin DJ , McCartyCA, PatchettR, SmithEM, WilkeRA: Pharmacogenetics of ophthalmic β-blockers.Personalized Med.5 , 377–385 (2008).
   PubMed Web of Science ®Google Scholar
• Peissig P , SirohiE, BergRL et al.: Construction of atorvastatin dose–response relationships using data from a large population-based DNA biobank. Basic Clin. Pharmacol. Toxicol.100 , 286–288 (2007).
   PubMed Web of Science ®Google Scholar
• Wilke RA , BergRL, LinnemanJG, Zhao C-F, McCarty CA, Krauss RM: Characterization of LDL-cholesterol lowering efficacy for atorvastatin in a population-based DNA biorepository. Basic Clin. Pharmacol. Toxicol. (2008) (In Press).
   PubMedGoogle Scholar
• Hillman MA , WilkeRA, CaldwellMD, BergR, GlurichI, BurmesterJK: Relative impact of covariates in prescribing warfarin according to CYP2C9-based genotype.Pharmacogenetics14 , 539–547 (2004).
   PubMedGoogle Scholar
• Wilke RA , BergRL, VidailletH, Caldwell MD, Burmester JK, Hillman MA: Impact of age, CYP2C9 genotype, and concomitant medication on the rate of rise for prothrombin time, during the first 30 days of warfarin therapy. Clin. Med. Res.3 , 207–213 (2005).
   PubMedGoogle Scholar
• Hillman MA , WilkeRA, YaleS et al.: A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data. Clin. Med. Res.3 , 137–145 (2005).
   PubMedGoogle Scholar
• Caldwell MD , BergRL, ZhangKQ et al.: Evaluation of genetic factors for warfarin dose prediction. Clin. Med. Res.5 , 8–16 (2007).
   PubMedGoogle Scholar
• Caldwell MD , AwadT, JohnsonJA et al.: CYP4F2 genetic variant alters required warfarin dose. Blood111 , 4106–4112 (2008).
   PubMed Web of Science ®Google Scholar
• Wilke RA , MooreJH, BurmesterJK: Relative impact of CYP3A genotype and concomitant medication on the severity of atorvastatin-induced muscle damage.Pharmacogenet. Genomics15 , 415–421 (2005).
   PubMed Web of Science ®Google Scholar
• Wilke RA , LinD, RodenDM et al.: Identifying genetic risk factors for serious adverse drug reactions – current progress and challenges. Nat. Rev. Drug Discov.6 , 904–916 (2007).
   PubMed Web of Science ®Google Scholar

Websites

• Marshfield Clinic Research Foundation Personalized Medicine Research Project www.marshfieldclinic.org/pmrp
   Google Scholar
• University of Wisconsin Institute for Clinical and Translational Research www.ictr.wisc.edu
   Google Scholar
• US NIH, National Cancer Institute: Risk factor monitoring and methods: diet history questionnaire (2007) http://riskfactor.cancer.gov/DHQ
   Google Scholar
• US NIH, National Cancer Institute: Risk factor monitoring and methods: diet history questionnaire: Diet*Calc Software (2007) http://riskfactor.cancer.gov/DHQ/dietcalc
   Google Scholar
• US NIH, National Institute of General Medical Sciences: Pharmacogenetics research network (2008) www.nigms.nih.gov/Initiatives/PGRN
   Google Scholar
• The eMERGE Network – Electronic Medical Records and Genomics www.gwas.org
   Google Scholar
• Pharmacogenetics Research Network www.nigms.nih.gov/Initiatives/PGRN
   Google Scholar
• HHS.gov: Personalised Health Care www.dhhs.gov/myhealthcare
   Google Scholar
• PharmGKB: The Pharmacogenetics and Pharmacogenomics Knowledge Base www.pharmgkb.org
   Google Scholar